Immunization of the E7 epitope with GM3 particles induced high-frequency E7-specific CD8<sup>+</sup> T cells and effectively reversed the tumor growth of large, established TC-1 tumors as an immune monotherapy. The gene discussed is CD8A; the disease is neoplasm.